Free delivery over $100 Learn more

30 days return period Learn more
SKU: 0152ATC

OVSAHO Human Specialized Cells

Tumor Cell Lines > Ovarian Cancer Cell Lines

Product Type: Human Ovarian Cancer Cell Lines

Species: Human

Cell Type: Other / Specialized Cells

Source Organ: Other

$1,249.00
Size

Care information

Display general product information or specific product information using metafields.

Delivery and Shipping

Add some general information about your delivery and shipping policies.

Cell Name: OVSAHO

Ovarian adenocarcinoma. Cells are transplantable to both mouse hypodermis and abdominal.

  • Description
    OVSAHO is a permanent epithelial ovarian carcinoma cell line derived from the abdominal metastatic tumor of a 56-year-old Japanese female with high-grade serous adenocarcinoma. The original tissue was a solid tumor from the ovary, making OVSAHO a widely used model in ovarian cancer research. These cells grow adherently in monolayer culture and display epithelial morphology with a moderately polygonal shape. OVSAHO cells express a variety of cytokeratins including CK6, CK7, CK8, CK14, CK15/16, CK18, and CK19. Cytogenetic analysis reveals a complex karyotype, and they harbor a TP53 nonsense mutation (c.1024C>T; p.Arg342Ter), while retaining wild-type BRCA1. The cells are tumorigenic in both immunodeficient and immunocompetent mice, forming tumors via subcutaneous, intraperitoneal, and orthotopic injection, but show no evidence of metastasis. They are HPV- and EBV-negative. This cell line offers a reliable preclinical platform for investigating serous ovarian carcinoma and p53-related pathways.
  • Product Name
    OVSAHO
  • Product Type
    Human Ovarian Cancer Cell Lines
  • Species
    Human
  • Product Type
    Human Ovarian Cancer Cell Lines
  • Growth Conditions
    37 °C, 5% CO2
  • Application
    The OVSAHO cell line is widely used in ovarian cancer research. As one of the frequently employed tumor models, it important for in vitro screening of experimental anticancer agents. Researchers can rely on OVSAHO to explore specific histologic subtypes and the response to various agents. Additionally, OVSAHO’s utility extends to xenograft models, where supports xenograft-based preclinical drug testing, contributing to the advancement of ovarian cancer treatment strategies.
  • Size/Quantity
    1 vial
  • Recommended Medium And Supplement

    RPMI 1640 + 10% FBS
  • Shipping Conditions
    Dry Ice
  • Storage
    Liquid Nitrogen
  • Biosafety Level
    1

Payment & Security

Payment methods

    Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.

    • Visit our support center

      Expert help & advice

    • Check your order status

      Updates & tracking

    • Returns & exchanges

      All you need to know

    • Price-match guarantee

      Our promise to you